DK0552138T3 - Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet. - Google Patents

Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet.

Info

Publication number
DK0552138T3
DK0552138T3 DK93830010.0T DK93830010T DK0552138T3 DK 0552138 T3 DK0552138 T3 DK 0552138T3 DK 93830010 T DK93830010 T DK 93830010T DK 0552138 T3 DK0552138 T3 DK 0552138T3
Authority
DK
Denmark
Prior art keywords
esters
pharmaceutical compositions
acylcarnitines
preparation
antimycotic activity
Prior art date
Application number
DK93830010.0T
Other languages
Danish (da)
English (en)
Inventor
Domenico Misiti
Maria Ornella Tinti
Mose Santaniello
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0552138T3 publication Critical patent/DK0552138T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK93830010.0T 1992-01-16 1993-01-15 Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet. DK0552138T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920028A IT1254136B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Publications (1)

Publication Number Publication Date
DK0552138T3 true DK0552138T3 (da) 1997-10-20

Family

ID=11400574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93830010.0T DK0552138T3 (da) 1992-01-16 1993-01-15 Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet.

Country Status (13)

Country Link
US (2) US5519056A (xx)
EP (1) EP0552138B1 (xx)
JP (1) JP3294652B2 (xx)
KR (1) KR100251887B1 (xx)
AT (1) ATE151744T1 (xx)
CA (1) CA2087084C (xx)
DE (1) DE69309725T2 (xx)
DK (1) DK0552138T3 (xx)
ES (1) ES2101998T3 (xx)
GR (1) GR3023163T3 (xx)
HK (1) HK1005864A1 (xx)
IT (1) IT1254136B (xx)
ZA (1) ZA93161B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258370B (it) * 1992-03-02 1996-02-26 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US5741816A (en) * 1994-06-20 1998-04-21 Tanabe Seiyaku Co., Ltd. Hair-growth agent
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283955B1 (it) * 1996-03-20 1998-05-07 Sigma Tau Ind Farmaceuti Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596147A5 (xx) * 1974-09-25 1978-02-28 Lonza Ag
CH588443A5 (xx) * 1974-09-25 1977-06-15 Lonza Ag
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1170861B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1191945B (it) * 1986-06-04 1988-03-31 Avantgarde Spa N-alchilammidi della d(+)-carnitina dotate di attivita' antibatterica,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1235494B (it) * 1987-12-02 1992-09-04 Avantgarde Spa N-alchilammidi della dl e l(-)carnitina dotate di attivita' antibatterica, procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Also Published As

Publication number Publication date
IT1254136B (it) 1995-09-08
ES2101998T3 (es) 1997-07-16
KR100251887B1 (ko) 2000-05-01
KR930016392A (ko) 1993-08-26
JPH05339219A (ja) 1993-12-21
ITRM920028A1 (it) 1993-07-16
GR3023163T3 (en) 1997-07-30
EP0552138B1 (en) 1997-04-16
JP3294652B2 (ja) 2002-06-24
DE69309725D1 (de) 1997-05-22
EP0552138A2 (en) 1993-07-21
US5525627A (en) 1996-06-11
HK1005864A1 (en) 1999-01-29
CA2087084A1 (en) 1993-07-17
EP0552138A3 (en) 1993-10-20
DE69309725T2 (de) 1997-07-31
ZA93161B (en) 1993-10-06
ATE151744T1 (de) 1997-05-15
ITRM920028A0 (it) 1992-01-16
US5519056A (en) 1996-05-21
CA2087084C (en) 2003-12-23

Similar Documents

Publication Publication Date Title
AU595948B2 (en) Transdermal flux enhancing compositions
HU9600116D0 (en) Fungicidal compositions containing benzophenone and process for preparation of the active ingredients and method for the control of fungi.
OA09039A (fr) Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques
ZA93162B (en) Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity.
DK0552138T3 (da) Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet.
AU1398892A (en) Pyrazolopyridine compound and processes for preparation thereof
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
KR840005068A (ko) 항균제의 제조방법
UA50706C2 (uk) Спосіб пригнічення фітопатогенних грибків, похідні бензофенону, спосіб захисту рослин від ушкоджень викликаних фітопатогенним грибком, фунгіцидна композиція та способи одержання бензофенонів
KR960029314A (ko) 사이클로스포린-a와 다른 면역억제제의 독성효과를 감소를 위한 l-카르니틴 및 알카노일 l-카르니틴 유도체의 용도
ATE43601T1 (de) Phosphorylalkanolamid-derivate von l-carnitin und sie enthaltende arzneimittel.
US3639623A (en) Topical pharmaceutical composition comprising certain quaternary ammonium compounds
NZ334119A (en) Use of pentynoic acid derivatives as neurotrophic and antiproliferative agents
US5002973A (en) Stabilized sulfite-free catecholamine compositions
CA2095526A1 (en) Compound and compositions useful as antifungal agents
SU1796185A1 (ru) Фунгицид 2
CA2203566A1 (en) Percutaneously administration preparation
US20050182124A1 (en) Ester bacteriostat for stabilizing cosmetics
IE39587B1 (en) Antibacterial compositions